Managing copper-associated liver disease in dogs — a preventable genetic condition causing chronic liver welfare impairment.
Copper storage hepatopathy causes insidious, progressive liver damage that may remain subclinical for years before overt liver disease develops. The chronic oxidative damage from copper accumulation progressively destroys hepatocytes and replaces functional liver tissue with fibrous scar. By the time clinical signs appear — jaundice, ascites, weight loss, neurological signs — significant irreversible liver damage has typically already occurred.
The welfare of acute copper toxicosis episodes is severely compromised. Massive hepatocellular death releases stored copper, causing haemolytic crisis — sudden destruction of red blood cells causing severe anaemia, jaundice, and collapse. The acute deterioration in copper toxicosis episodes is dramatic and distressing.
Management with copper-chelating agents (D-penicillamine or trientine) reduces hepatic copper content and slows disease progression in cases detected before cirrhosis develops. Dietary copper restriction limits further accumulation. Genetic testing in predisposed breeds allows early identification of affected animals for proactive management.